Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of AMG 706 plus
panitumumab when administered with either FOLFIRI or FOLFOX4 chemotherapy regimens. This is a
Phase 1b clinical study.